HAP Trading’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-109,900
Closed -$41K 1959
2022
Q3
$41K Buy
109,900
+700
+0.6% +$365 ﹤0.01% 1037
2022
Q2
$46K Buy
109,200
+98,900
+960% +$44.1K ﹤0.01% 1087
2022
Q1
$33K Sell
10,300
-13,300
-56% -$10.2K ﹤0.01% 1381
2021
Q4
$53K Buy
23,600
+400
+2% +$618 ﹤0.01% 1457
2021
Q3
$43K Sell
23,200
-5,800
-20% -$13K ﹤0.01% 1562
2021
Q2
$41K Sell
29,000
-700
-2% -$1.75K ﹤0.01% 1550
2021
Q1
$42K Buy
+29,700
New +$108K ﹤0.01% 1217
2018
Q3
Sell
-954
Closed -$10K 1212
2018
Q2
$10K Buy
+954
New +$34.7K ﹤0.01% 870

Other funds holding ASXC

HAP Trading's ASXC Position: Q2 2021 in Review

HAP Trading sold out of Asensus Surgical, Inc. (ASXC) in Q2 2021, closing a stake of 64,273 shares — an estimated $161K sold.

HAP Trading first reported a position in ASXC in Q1 2021 and held it in 1 quarter. The position peaked at $209K in Q1 2021. 119 funds tracked by Wall St. Rank hold ASXC as of Q2 2021.

  • HAP Trading reported no remaining Asensus Surgical, Inc. position as of Q2 2021 after selling out during the quarter.
  • HAP Trading sold 64,273 Asensus Surgical, Inc. shares in Q2 2021, an estimated $161K.
  • HAP Trading first reported a position in Asensus Surgical, Inc. in Q1 2021 and held it in 1 quarter.
  • HAP Trading's Asensus Surgical, Inc. position peaked at $209K in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2021.

Based on HAP Trading's 13F filing for Q2 2021, filed 11 Aug 2021.